Global Non-Human Primates for Experiment 麻豆原创 Research Report 2024

Publication ID:

PB507242023

Publication Date:

July 15, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Non-Human Primates for Experiment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 310%.
This report aims to provide a comprehensive presentation of the global market for Non-Human Primates for Experiment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Human Primates for Experiment.
Report Scope
The Non-Human Primates for Experiment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Human Primates for Experiment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Human Primates for Experiment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
WuXi AppTec
Joinn Laboratories
Pharmaron Inc
Jinggang Biotech
Topgene Biotechnology
Landao Biotechnology
Segment by Type
Rhesus Monkey
Cynomolgus Monkey
Segment by Application
Pharmaceutical Company
Hospital
Scientific Institutional Center
School
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Human Primates for Experiment companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Non-Human Primates for Experiment 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rhesus Monkey
1.2.3 Cynomolgus Monkey
1.3 麻豆原创 by Application
1.3.1 Global Non-Human Primates for Experiment 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Company
1.3.3 Hospital
1.3.4 Scientific Institutional Center
1.3.5 School
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Human Primates for Experiment 麻豆原创 Perspective (2019-2030)
2.2 Non-Human Primates for Experiment Growth Trends by Region
2.2.1 Global Non-Human Primates for Experiment 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-Human Primates for Experiment Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Non-Human Primates for Experiment Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Non-Human Primates for Experiment 麻豆原创 Dynamics
2.3.1 Non-Human Primates for Experiment Industry Trends
2.3.2 Non-Human Primates for Experiment 麻豆原创 Drivers
2.3.3 Non-Human Primates for Experiment 麻豆原创 Challenges
2.3.4 Non-Human Primates for Experiment 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Human Primates for Experiment Players by Revenue
3.1.1 Global Top Non-Human Primates for Experiment Players by Revenue (2019-2024)
3.1.2 Global Non-Human Primates for Experiment Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Non-Human Primates for Experiment 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Human Primates for Experiment Revenue
3.4 Global Non-Human Primates for Experiment 麻豆原创 Concentration Ratio
3.4.1 Global Non-Human Primates for Experiment 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Human Primates for Experiment Revenue in 2023
3.5 Non-Human Primates for Experiment Key Players Head office and Area Served
3.6 Key Players Non-Human Primates for Experiment Product Solution and Service
3.7 Date of Enter into Non-Human Primates for Experiment 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Human Primates for Experiment Breakdown Data by Type
4.1 Global Non-Human Primates for Experiment Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Non-Human Primates for Experiment Forecasted 麻豆原创 Size by Type (2025-2030)
5 Non-Human Primates for Experiment Breakdown Data by Application
5.1 Global Non-Human Primates for Experiment Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Non-Human Primates for Experiment Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Non-Human Primates for Experiment 麻豆原创 Size (2019-2030)
6.2 North America Non-Human Primates for Experiment 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-Human Primates for Experiment 麻豆原创 Size by Country (2019-2024)
6.4 North America Non-Human Primates for Experiment 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Human Primates for Experiment 麻豆原创 Size (2019-2030)
7.2 Europe Non-Human Primates for Experiment 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-Human Primates for Experiment 麻豆原创 Size by Country (2019-2024)
7.4 Europe Non-Human Primates for Experiment 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Human Primates for Experiment 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Non-Human Primates for Experiment 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-Human Primates for Experiment 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Non-Human Primates for Experiment 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Human Primates for Experiment 麻豆原创 Size (2019-2030)
9.2 Latin America Non-Human Primates for Experiment 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-Human Primates for Experiment 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Non-Human Primates for Experiment 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Human Primates for Experiment 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Non-Human Primates for Experiment 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-Human Primates for Experiment 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Non-Human Primates for Experiment 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Detail
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec Non-Human Primates for Experiment Introduction
11.1.4 WuXi AppTec Revenue in Non-Human Primates for Experiment Business (2019-2024)
11.1.5 WuXi AppTec Recent Development
11.2 Joinn Laboratories
11.2.1 Joinn Laboratories Company Detail
11.2.2 Joinn Laboratories Business Overview
11.2.3 Joinn Laboratories Non-Human Primates for Experiment Introduction
11.2.4 Joinn Laboratories Revenue in Non-Human Primates for Experiment Business (2019-2024)
11.2.5 Joinn Laboratories Recent Development
11.3 Pharmaron Inc
11.3.1 Pharmaron Inc Company Detail
11.3.2 Pharmaron Inc Business Overview
11.3.3 Pharmaron Inc Non-Human Primates for Experiment Introduction
11.3.4 Pharmaron Inc Revenue in Non-Human Primates for Experiment Business (2019-2024)
11.3.5 Pharmaron Inc Recent Development
11.4 Jinggang Biotech
11.4.1 Jinggang Biotech Company Detail
11.4.2 Jinggang Biotech Business Overview
11.4.3 Jinggang Biotech Non-Human Primates for Experiment Introduction
11.4.4 Jinggang Biotech Revenue in Non-Human Primates for Experiment Business (2019-2024)
11.4.5 Jinggang Biotech Recent Development
11.5 Topgene Biotechnology
11.5.1 Topgene Biotechnology Company Detail
11.5.2 Topgene Biotechnology Business Overview
11.5.3 Topgene Biotechnology Non-Human Primates for Experiment Introduction
11.5.4 Topgene Biotechnology Revenue in Non-Human Primates for Experiment Business (2019-2024)
11.5.5 Topgene Biotechnology Recent Development
11.6 Landao Biotechnology
11.6.1 Landao Biotechnology Company Detail
11.6.2 Landao Biotechnology Business Overview
11.6.3 Landao Biotechnology Non-Human Primates for Experiment Introduction
11.6.4 Landao Biotechnology Revenue in Non-Human Primates for Experiment Business (2019-2024)
11.6.5 Landao Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

WuXi AppTec
Joinn Laboratories
Pharmaron Inc
Jinggang Biotech
Topgene Biotechnology
Landao Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.